Aussie Drug Lobbyist Argues For Reduced Taxes, Laws On Clinical Trials
This article was originally published in PharmAsia News
Executive Summary
Australia’s corporate taxes and laws governing intellectual property are deterrents to foreign investment, the drug industry asserted in lobbying effort.